More detailed mechanistic studies are needed to determine whether this BMAL1-MEX3A-Lgr5 regulation is circadian dependent which may provide insights into the mechanisms of chrono-therapeutic response and could facilitate development of more effective treatment strategies for intestinal cancer and other diseases. This evidence concerns the gene MEX3A and intestinal cancer.